Xenetic Biosciences, Inc. — Rendiconto Finanziario Trimestrale (NASDAQ:XBIO) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 7.74 M
Employee 2
Founded 1997
CEO N/A
Website www.xeneticbio.com
Headquarter Nevada, United States
FIGI BBG0028WJXC0
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

7.74 M Capitalizzazione di mercato

Rapporto prezzo/utili

-1.37

Rapporto prezzo/fatturato

1.24

Notizie

Xenetic Biosciences estende la collaborazione con Scripps Research

Xenetic Biosciences extends collaboration with Scripps Research

Amneal Pharmaceuticals (AMRX) Beats Q3 Earnings and Revenue Estimates

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges - Galecto (NASDAQ:GLTO), Micron Technology (NASDAQ:MU), Xenetic Biosciences (NASDAQ:XBIO)

Xenetic Biosciences fissa il prezzo dell’offerta di azioni ordinarie a 4,5 milioni di dollari

Xenetic Biosciences prices $4.5 million common stock offering

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings - Galecto (NASDAQ:GLTO)

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Ambow Education Holding (AMEX:AMBO)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.00%

Nasdaq Gains 150 Points; US Mortgage Applications Decline - AlphaTON Capital (NASDAQ:ATON), Envoy Medical (NASDAQ:COCH)

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Acurx Pharmaceuticals (NASDAQ:ACXP), AlphaTON Capital (NASDAQ:ATON)

Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates